↓ Skip to main content

Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library

Overview of attention for article published in Frontiers in oncology, August 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library
Published in
Frontiers in oncology, August 2022
DOI 10.3389/fonc.2022.893951
Pubmed ID
Authors

Jisun Oh, Hyun−Ju An, Hyun Jeong Yeo, Sujin Choi, Jisu Oh, Segi Kim, Jin Man Kim, Junwon Choi, Soonchul Lee

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 27%
Student > Ph. D. Student 2 18%
Student > Bachelor 1 9%
Student > Doctoral Student 1 9%
Professor > Associate Professor 1 9%
Other 0 0%
Unknown 3 27%
Readers by discipline Count As %
Medicine and Dentistry 3 27%
Pharmacology, Toxicology and Pharmaceutical Science 2 18%
Biochemistry, Genetics and Molecular Biology 2 18%
Physics and Astronomy 1 9%
Unknown 3 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2023.
All research outputs
#3,483,899
of 26,169,168 outputs
Outputs from Frontiers in oncology
#1,035
of 22,913 outputs
Outputs of similar age
#70,633
of 436,439 outputs
Outputs of similar age from Frontiers in oncology
#61
of 1,811 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,439 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 1,811 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.